Hematologic Diseases: Clinical Trials

87 trials for Hematologic Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

87 terminated. 87 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 487Terminated 87

Follow Hematologic Diseases: new trials by email Literature Review of Hematologic Diseases trials Research Report on Hematologic Diseases

Trials (filtered) newest first · largest first

All 87 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Levofloxacin, Placebo - Neutropenic Fever, Acute Lymphoblastic Leukemia
Phase 4TerminatedGadjah Mada University492026-01-012026-10-01
IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
Ferric Carboxymaltose, Ferrous Sulfate - Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF)
Phase 4TerminatedSyed Hamza Mufarrih422025-04-022026-07-20
Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure
IV Iron Infusion Group - Heart Failure, Iron-deficiency
Phase 4TerminatedRadha Gopalan62024-01-242026-07-29
Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery
Prothrombin Complex Concentrate, Human, Fresh Frozen Plasma - Valvular Heart Surgery
Phase 4TerminatedSHI Jia4762023-10-252026-06-24
An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa
Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US), Haemophilia Joint Health Score (HJHS) - Hemophilia A, Hemophilia B
Phase 4TerminatedSwedish Orphan Biovitrum102023-08-242025-01-16
Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors
Hydroxyurea - Polycythemia Vera
Phase 4TerminatedNovartis Pharmaceuticals762023-07-282026-08-18
Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
Ceftolozane / Tazobactam Injection - Pneumonia, Hematologic Malignancy
Phase 4TerminatedWeill Medical College of Cornell University172023-01-102026-01-21
Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL
Flumatinib, Imatinib - Acute Leukemia
Phase 4TerminatedInstitute of Hematology & Blood Diseases Hospital, China392021-09-162025-05-01
Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)
Blinatumomab, Current Wearable Heatlth Monitoring System (CWHMS) - B-precursor Acute Lymphoblastic Leukemia
Phase 4TerminatedAmgen102021-08-262025-05-18
NIRAPK : Study of the Relationship(s) Between Clinical, Biological and Pharmacokinetic Metrics and Toxicities When Niraparib is Used as Maintenance Treatment for Ovarian Cancer Patients.
Pharmacokinetics, Dosage of Niraparib - Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer
Phase 4TerminatedHospices Civils de Lyon122021-05-052025-05-22
Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic Indexes
Rifaximin, Placebo - Liver Cirrhosis, Coagulation Disorder
Phase 4TerminatedUniversity of Roma La Sapienza202021-04-032024-10-08
Factor In the Initial Resuscitation of Severe Trauma 2 Patients
Fibrinogen + PCC, Frozen Plasma - Traumatic Hemorrhage, Coagulopathy
Phase 4TerminatedUniversity Health Network, Toronto1422021-04-012026-10-21
Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder
Ferrous sulfate - Sleep Disorder, Restless Legs Syndrome
Phase 4TerminatedMayo Clinic62020-11-162024-05-22
Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy
Ferrous sulfate - Pregnancy Related, Iron Deficiency Anemia of Pregnancy
Phase 4TerminatedThe University of Texas Medical Branch, Galveston142020-10-272024-06-24
Desmopressin for Bedwetting in Children With SCD
Desmopressin - Nocturnal Enuresis, Anemia, Sickle Cell
Phase 4TerminatedMontefiore Medical Center82020-07-072024-05-07
Study to Assess Feasibility and Safety of Iron Repletion With Feraheme in Iron Deficient Patients With Durable Ventricular Assist Device Support
Ferumoxytol injection - Anemia
Phase 4TerminatedNYU Langone Health12020-01-152023-07-18
N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric Leukemia
N-Acetylcysteine, Placebo - Lymphoblastic Leukemia, Acute, Childhood
Phase 4TerminatedTeny Tjitra Sari162019-08-292022-11-09
Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia
Outpatient Care Model, CPX-351 - Leukemia, Myeloid, Acute
Phase 4TerminatedMedical College of Wisconsin32019-08-282022-07-19
ORal IrON Supplementation With Ferric Maltol in Patients With Heart Failure Carrying Left Ventricular Assist Devices
Ferric maltol 30 mg (Feraccru®) - Heart Failure, Left Sided, Anemia, Iron Deficiency
Phase 4TerminatedHannover Medical School112019-03-182020-04-21
Study of Emicizumab Prophylaxis in Participants With Hemophilia A With or Without Inhibitors Undergoing Minor Surgical Procedures
Emicizumab - Hemophilia A
Phase 4TerminatedGenentech, Inc.142018-06-282021-03-01

Showing 20 of 87. Sign in to see all of them.

Narrower conditions

Anemia (26)  ·  Anemia, Iron-Deficiency (9)  ·  Hemophilia A (8)  ·  Kidney Failure, Chronic (7)  ·  Anemia, Sickle Cell (6)  ·  Hemostatic Disorders (6)  ·  Renal Insufficiency, Chronic (6)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  Thrombocytopenia (5)  ·  Leukemia (4)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (4)  ·  Febrile Neutropenia (3)  ·  Heart Failure (3)  ·  Hemophilia B (3)  ·  Iron Deficiencies (3)

Broader conditions

Hemic and Lymphatic Diseases (87)  ·  Pathological Conditions, Signs and Symptoms (26)  ·  Pathologic Processes (23)  ·  Neoplasms (21)  ·  Disease Attributes (19)  ·  Chronic Disease (18)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (18)  ·  Genetic Diseases, Inborn (18)  ·  Neoplasms by Histologic Type (17)  ·  Immune System Diseases (16)  ·  Anemia (15)  ·  Hemorrhagic Disorders (15)  ·  Urogenital Diseases (15)  ·  Metabolic Diseases (14)

Interventions

Epoetin Alfa (8)  ·  ferric carboxymaltose (8)  ·  ferrous sulfate (5)  ·  epoetin beta (4)  ·  Erythropoietin (3)  ·  Iron (3)  ·  Cyclophosphamide (2)  ·  Deferasirox (2)  ·  Deferiprone (2)  ·  F8 protein, human (2)  ·  Ibuprofen (2)  ·  Imatinib Mesylate (2)  ·  Ketamine (2)  ·  Rituximab (2)  ·  Sodium Chloride (2)

Sponsors

Hoffmann-La Roche (7)  ·  Novartis Pharmaceuticals (4)  ·  Ortho Biotech Products, L.P. (3)  ·  Pfizer (3)  ·  Amgen (2)  ·  ApoPharma (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  University Health Network, Toronto (2)  ·  Weill Medical College of Cornell University (2)  ·  Basque Health Service (1)  ·  Bayer (1)  ·  Bio Products Laboratory (1)  ·  Brooke Army Medical Center (1)  ·  CANDLE-KIT Trial Study Group (1)  ·  Catharina Ziekenhuis Eindhoven (1)

Countries

United States (35)  ·  France (8)  ·  Germany (8)  ·  Italy (8)  ·  Spain (7)  ·  United Kingdom (6)  ·  Canada (4)  ·  Belgium (3)  ·  China (3)  ·  Greece (3)  ·  Indonesia (3)  ·  Netherlands (3)  ·  Russia (3)  ·  Saudi Arabia (3)  ·  Austria (2)

Top investigators

Janet Kwiatkowski, MD (2)  ·  Andrew Talal, MD (1)  ·  Anna Maria van Eijk, MD PhD (1)  ·  Arjunan Ganesh, MD (1)  ·  Caroline Dore, BSc (1)  ·  Charles T. Quinn, MD (1)  ·  Chul-won Choi, M.D. (1)  ·  Chul-won Jung, M.D. (1)

Results publications

PMID 36791280, PMID 17108343, PMID 20178723, PMID 21876446, PMID 25344113, PMID 27288381, PMID 28492441, PMID 29426286, PMID 30051186, PMID 30208456, PMID 30853478, PMID 31753773, PMID 32331365, PMID 32572189, PMID 33041718, PMID 33314078, PMID 34479938, PMID 34847228, PMID 35144945, PMID 35235189, PMID 35363499, PMID 35706490, PMID 35956390, PMID 36018224, PMID 36408876, PMID 37280083, PMID 37807937, PMID 37807952, PMID 38007586, PMID 38484432, PMID 38828109, PMID 39164407, PMID 39185895, PMID 39443013, PMID 40982282

NIH funding

2016 (1), I01CX001449 (1), P01CA128115 (1), U01DK071633 (1), U54HL070588 (1)